enGene Holdings Inc has a consensus price target of $25.8 based on the ratings of 10 analysts. The high is $34 issued by Morgan Stanley on March 11, 2025. The low is $7 issued by UBS on February 14, 2025. The 3 most-recent analyst ratings were released by Morgan Stanley, HC Wainwright & Co., and Piper Sandler on March 11, 2025, March 11, 2025, and February 18, 2025, respectively. With an average price target of $28.33 between Morgan Stanley, HC Wainwright & Co., and Piper Sandler, there's an implied 613.69% upside for enGene Holdings Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/11/2025 | Buy Now | 756.42% | Morgan Stanley | Jeffrey Hung50% | $37 → $34 | Maintains | Overweight | Get Alert |
03/11/2025 | Buy Now | 529.72% | HC Wainwright & Co. | Andres Maldonado41% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
02/18/2025 | Buy Now | 554.91% | Piper Sandler | Allison Bratzel62% | → $26 | Initiates | → Overweight | Get Alert |
02/14/2025 | Buy Now | 76.32% | UBS | Colin Bristow40% | $34 → $7 | Downgrade | Buy → Neutral | Get Alert |
12/23/2024 | Buy Now | 353.4% | JMP Securities | Silvan Tuerkcan45% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
12/23/2024 | Buy Now | 529.72% | HC Wainwright & Co. | Andres Maldonado41% | → $25 | Initiates | → Buy | Get Alert |
12/06/2024 | Buy Now | 353.4% | JMP Securities | Silvan Tuerkcan45% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
11/27/2024 | Buy Now | 479.35% | Raymond James | Sean McCutcheon12% | → $23 | Initiates | → Outperform | Get Alert |
11/18/2024 | Buy Now | 353.4% | JMP Securities | Silvan Tuerkcan45% | → $18 | Initiates | → Market Outperform | Get Alert |
09/24/2024 | Buy Now | 655.67% | Oppenheimer | Leland Gershell68% | $30 → $30 | Reiterates | Outperform → Outperform | Get Alert |
09/11/2024 | Buy Now | 907.56% | Morgan Stanley | Jeffrey Hung50% | $40 → $40 | Maintains | Overweight | Get Alert |
08/28/2024 | Buy Now | 655.67% | Oppenheimer | Leland Gershell68% | → $30 | Initiates | → Outperform | Get Alert |
04/22/2024 | Buy Now | 655.67% | Wells Fargo | Yanan Zhu36% | → $30 | Initiates | → Overweight | Get Alert |
04/15/2024 | Buy Now | 756.42% | Guggenheim | Manuel Navas24% | → $34 | Initiates | → Buy | Get Alert |
03/28/2024 | Buy Now | 831.99% | UBS | Colin Bristow40% | → $37 | Initiates | → Buy | Get Alert |
03/08/2024 | Buy Now | 907.56% | Morgan Stanley | Jeffrey Hung50% | → $40 | Initiates | → Overweight | Get Alert |
02/20/2024 | Buy Now | 680.86% | Leerink Partners | Mani Foroohar48% | → $31 | Initiates | → Outperform | Get Alert |
The latest price target for enGene Holdings (NASDAQ:ENGN) was reported by Morgan Stanley on March 11, 2025. The analyst firm set a price target for $34.00 expecting ENGN to rise to within 12 months (a possible 756.42% upside). 13 analyst firms have reported ratings in the last year.
The latest analyst rating for enGene Holdings (NASDAQ:ENGN) was provided by Morgan Stanley, and enGene Holdings maintained their overweight rating.
There is no last upgrade for enGene Holdings
The last downgrade for enGene Holdings Inc happened on February 14, 2025 when UBS changed their price target from $34 to $7 for enGene Holdings Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of enGene Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for enGene Holdings was filed on March 11, 2025 so you should expect the next rating to be made available sometime around March 11, 2026.
While ratings are subjective and will change, the latest enGene Holdings (ENGN) rating was a maintained with a price target of $37.00 to $34.00. The current price enGene Holdings (ENGN) is trading at is $3.97, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.